JERUSALEM, March 27 (Xinhua) -- An Israeli-led research team has developed a potential new treatment for head and neck cancer (HNC), using a targeted drug and immunotherapy, Ben Gurion University (BGU) in southern Israel announced on Sunday.
The findings, co-authored by Israeli, Chinese, French, German and U.S. researchers, were published in the Journal for ImmunoTherapy of Cancer on Sunday.
